During the past decade, Apotheke im MSZ conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Apotheke im MSZ" are "Osteoarthritis" (2 trials). Many other conditions were trialed in "Apotheke im MSZ" in a lesser frequency.

Most popular intervention types in "Apotheke im MSZ" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "IV placebo" (1 trials), "diclofenac" (1 trials), "oxycodone" (1 trials), "placebo" (1 trials) and "tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apotheke im MSZ" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Apotheke im MSZ". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Apotheke im MSZ, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Apotheke im MSZ, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".